Who is sponsoring NCT06144736?

NCT06144736 is sponsored by Heinrich-Heine University, Duesseldorf.

What drugs are being tested in NCT06144736?

Interventions in NCT06144736: Robot-assisted retroperitoneal lymph node dissection, Adjuvant therapy with one cycle of cisplatin, etoposide and bleomycin.

Is NCT06144736 still recruiting?

NCT06144736 is currently recruiting now. Last updated 15 September 2025.

Last reviewed 2025-09-15 · How we verify

NCT06144736

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND

Recruiting now Phase 2 Last updated 15 September 2025

What this trial tests

Phase 2 trial testing Robot-assisted retroperitoneal lymph node dissection in Seminoma in 60 participants. Currently enrolling.

Timeline

28 August 2023

Primary endpoint
31 August 2026

31 August 2029

Quick facts

Lead sponsor	Heinrich-Heine University, Duesseldorf
Phase	Phase 2
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	28 August 2023
Primary completion	31 August 2026
Estimated completion	31 August 2029
Sites	1 location across Germany

Drugs / interventions tested

Robot-assisted retroperitoneal lymph node dissection
Adjuvant therapy with one cycle of cisplatin, etoposide and bleomycin — full drug profile →

Conditions studied

Seminoma — all drugs for Seminoma →

Sponsor

Heinrich-Heine University, Duesseldorf

Who can join

Adults 18 to 99, male only, with Seminoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

PRIMETEST II is an interventional study involving low-volume metastatic seminoma. It explores a novel approach using robot-assisted primary retroperitoneal lymph node dissection, aiming to reduce long-term side effects and improve quality of life. By identifying factors predicting cancer recurrence, the study hopes to tailor treatments for better outcomes. The approach could potentially spare patients from chemotherapy induced long-term side effects while maintaining excellent survival rates, presenting a promising shift in testicular cancer care for this specific patient group.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Matched-pair analysis of peri-operative and oncological outcomes of robot-assisted vs open retroperitoneal lymph node dissection.
Pongratanakul P, Vermeulen-Spohn M, Wöltjen C, Thy S, et al · · 2025 · cited 5× · PMID 40260829 · DOI 10.1111/bju.16747

Verify or expand the search:

Other recruiting trials for Seminoma

Currently open trials in the same condition.

NCT07498959 — Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer · NA · recruiting
NCT06309745 — THERApy De-escalation for TESTicular Cancer · recruiting
NCT06133543 — Robot-assisted ICG-guided Sentinel Node Biopsy in Testicular Cancer · NA · recruiting
NCT05529251 — De-escalation Study for Stage IIa/IIb < 3 cm Seminoma · Phase 2 · recruiting
NCT05142982 — Radiotherapy vs Observation for Post Chemotherapy Residual Mass in Advanced Seminoma · NA · recruiting

Other Heinrich-Heine University, Duesseldorf trials

Trials by the same sponsor.

NCT04993508 — Randomized Prospective Multi Center Cohort Study for Primary Diagnosis of Clinically Significant Prostate Cancer With Co · NA · not yet recruiting
NCT07385482 — Chronic and Acute Cardiovascular Diseases in Elderly Intensive Care Patients · not yet recruiting
NCT07455097 — COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P) · active not recruiting
NCT07254663 — GEL & MEDication Dysphagia · recruiting
NCT06313944 — German Registry of Alzheimer's Disease Treated With Transcranial Pulse Stimulation · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06144736 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Heinrich-Heine University, Duesseldorf
Last refreshed: 15 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06144736.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing